AMA
Varma T, Sahitya D, Dusad S, Agarwal A, Dayal D. Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(2):106-109.
APA
Varma, T., Sahitya, D., Dusad, S., Agarwal, A., & Dayal, D. (2018). Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome. Pediatric Endocrinology Diabetes and Metabolism, 24(2), 106-109.
Chicago
Varma, Tandra, Dangudubiyyam Sahitya, Santosh Dusad, Ashish Agarwal, and Devi Dayal. 2018. "Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome". Pediatric Endocrinology Diabetes and Metabolism 24 (2): 106-109.
Harvard
Varma, T., Sahitya, D., Dusad, S., Agarwal, A., and Dayal, D. (2018). Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome. Pediatric Endocrinology Diabetes and Metabolism, 24(2), pp.106-109.
MLA
Varma, Tandra et al. "Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome." Pediatric Endocrinology Diabetes and Metabolism, vol. 24, no. 2, 2018, pp. 106-109.
Vancouver
Varma T, Sahitya D, Dusad S, Agarwal A, Dayal D. Oral prednisolone for management of persistent hypercalcemia after hypercalcemic crisis in the Williams-Beuren syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(2):106-109.
